Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Allsup

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing|December 1, 1994
Use of the intermittent pneumatic compression device in venous ulcer diseaseD J Allsup
Blood Reviews|September 28, 2002
The diagnosis and treatment of hairy-cell leukaemiaD J Allsup, J C Cawley
British Journal of Pharmacology|December 1, 1989
Comparison of P2 receptors of aortic endothelial cells with those of adrenal medulla non-chromaffin cellsD J Allsup, M R Boarder
Clinical and Experimental Medicine|December 16, 2004
Diagnosis, biology and treatment of hairy-cell leukaemiaD J Allsup, J C Cawley
Molecular Pharmacology|July 1, 1990
Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate responseD J Allsup, M R Boarder
Postgraduate Medical Journal|August 30, 2000
A pulmonary mass and hyperviscosityJ A Corless, D J Allsup, T J Deeble, et al.
Clinical and Laboratory Haematology|September 27, 2006
Inhaled nitrous oxide (Entonox) as a short acting sedative during bone marrow examinationB Steedman, J Watson, S Ali, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing|December 1, 1994
Use of the intermittent pneumatic compression device in venous ulcer diseaseD J Allsup
Blood Reviews|September 28, 2002
The diagnosis and treatment of hairy-cell leukaemiaD J Allsup, J C Cawley
British Journal of Pharmacology|December 1, 1989
Comparison of P2 receptors of aortic endothelial cells with those of adrenal medulla non-chromaffin cellsD J Allsup, M R Boarder
Clinical and Experimental Medicine|December 16, 2004
Diagnosis, biology and treatment of hairy-cell leukaemiaD J Allsup, J C Cawley
Molecular Pharmacology|July 1, 1990
Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate responseD J Allsup, M R Boarder
Postgraduate Medical Journal|August 30, 2000
A pulmonary mass and hyperviscosityJ A Corless, D J Allsup, T J Deeble, et al.
Clinical and Laboratory Haematology|September 27, 2006
Inhaled nitrous oxide (Entonox) as a short acting sedative during bone marrow examinationB Steedman, J Watson, S Ali, et al.
Leukemia|March 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLLD R Howard, T Munir, L McParland, et al.
Leukemia|January 22, 2010
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemiaJ M Allan, N J Sunter, J R Bailey, et al.
Leukemia|November 4, 2014
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskG P Sava, H E Speedy, M C Di Bernardo, et al.
Pageof 1